The WHO Therapeutics and Covid-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of Covid-19.

This eighth version of the WHO living guideline now contains 14 recommendations, including three new recommendations regarding Janus kinase (JAK) inhibitors and sotrovimab. No further updates to the previous existing recommendations were made in this latest version.

Report by the World Health Organization